Resistance: Drugs & Bugs in Dermatology

4 (1 vote)

Recorded On: 06/08/2024

Only available as part of a package

Stephen Tyring, MD, PhD

Antimicrobial resistance (AMR) in dermatology (and medicine in general) has become a global problem due to inappropriate use of antibiotics. Microbes have developed multiple pathways to resist available antibiotics, which has resulted in major health and economic challenges. Although prevention of AMR is critical, new treatment measures are under study.

At the end of this session, participants will be able to:

Understand the reasons for antimicrobial resistance (AMR) in dermatology
Understand the mechanisms of AMR
Review prevention measures for AMR
Explore new methods of treating AMR

Stephen Tyring, MD, PhD, MBA

Medical Director

Dermatological Association of Texas (Houston Skin Associates)

Dr. Tyring is the Medical Director of the Dermatological Association of Texas (Houston Skin Associates) and the Center for Clinical Studies. He is also Adjunct Professor in the Departments of Dermatology, Microbiology/Molecular Genetics and Internal Medicine (Division of Infectious Diseases) at the McGovern School of Medicine at the University of Texas Health Sciences Center, Houston.

He is a principal investigator on over 400 successfully completed clinical trials, Dr. Tyring is an author of over 1000 journal articles and book chapters as well as 11 books, most recently Overcoming Antimicrobial Resistance of the Skin (2021).

Dr. Tyring received his undergraduate degree from Indiana State University, his Master’s Degree from Abilene Christian University, his PhD from Texas Tech University, his MD from the University of Texas Medical Branch and his MBA from Rice University. He completed his dermatology residency at the University of Alabama School of Medicine.